(KEI blogs and other work on COVID-19 are here: https://www.keionline.org/coronavirus) A letter from Costa Rica, signed by Carlos Alarado Quesada, the President, and Dr. Daniel Salas Peraza, the Minister of Health, to Dr. Tedros Adhanom Ghebreyesus, was sent this evening… Continue Reading →
Resolution to require the National Government to establish compulsory licenses and other measures to guarantee free and affordable access to pharmaceutical products and medical technologies in the Declaration of Sanitary Emergency due to the Coronavirus pandemic (COVID-19) and other variations,… Continue Reading →
COVID-19 Gov’t Contracts: KEI has obtained numerous contracts between the federal government and pharmaceutical companies regarding COVID-19 medical technologies via the Freedom of Information act. For these and other contracts, please see: https://www.keionline.org/covid-contracts. COVID-19 Vaccine Manufacturing: KEI has gathered data… Continue Reading →
For more on KEI’s work on COVID-19, see keonline.org/coronavirus. Today, with an overwhelming 127 votes in favor and 0 votes against, the Chilean Chamber of Deputies approved a strong resolution asking the Chilean Government to declare that there is justification… Continue Reading →
For more on KEI’s work on COVID-19, see keonline.org/coronavirus. Global health emergencies such as the COVID-19 pandemic call upon us to answer to the better angels of our nature. Not all are heeding that call. Instead of cooperation and selflessness,… Continue Reading →
For more on KEI’s work on COVID-19, see keonline.org/coronavirus. As the US and other governments begin to expend large amounts of money on research and development related to the control, prevention and treatment of the coronavirus pandemic, there are important… Continue Reading →
Updated between 11 March 2020 to 18 March 2020 to include reactions from stakeholders on the nomination of Daren Tang (Singapore) as Director General of the World Intellectual Property Organization (WIPO) Brook K. Baker, Senior Policy Analyst Health GAP (Global… Continue Reading →
Berne Convention revisions, and the evolution of its limitations and exceptions to copyright, includes a discussion of the quotation right issues addressed also by Ricketson. WIPO Studies and Reports The sections of SCCR9/7, the April 5, 2003 study on copyright… Continue Reading →
This is the KEI request to appear at the January 30, 2020, USTR public hearing on petitions from the IIPA to impose higher tariffs (revoke GSP benefits) on South Africa and Indonesia over copyright issues. The docket is here: https://www.regulations.gov/document?D=USTR-2019-0020-0001… Continue Reading →
KEI filed these comments on the NIH Draft Policy for Data Management and Sharing and Supplemental DRAFT Guidance January 10, 2019 1621 Connecticut Avenue NW Suite 500 Washington, DC 20009 www.keionline.org January 10, 2020 Office of Science Policy National Institutes… Continue Reading →